These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 17296752)

  • 1. Mucosal and systemic immune responses in patients with diarrhea due to CS6-expressing enterotoxigenic Escherichia coli.
    Qadri F; Ahmed T; Ahmed F; Bhuiyan MS; Mostofa MG; Cassels FJ; Helander A; Svennerholm AM
    Infect Immun; 2007 May; 75(5):2269-74. PubMed ID: 17296752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of a non-toxigenic Escherichia coli oral vaccine strain expressing large amounts of CS6 and inducing strong intestinal and serum anti-CS6 antibody responses in mice.
    Tobias J; Svennerholm AM; Carlin NI; Lebens M; Holmgren J
    Vaccine; 2011 Nov; 29(48):8863-9. PubMed ID: 21983363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Over-expression of major colonization factors of enterotoxigenic Escherichia coli, alone or together, on non-toxigenic E. coli bacteria.
    Tobias J; Holmgren J; Hellman M; Nygren E; Lebens M; Svennerholm AM
    Vaccine; 2010 Oct; 28(43):6977-84. PubMed ID: 20728524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune response in diarrheal patients and asymptomatic carrier with CS6-producing enterotoxigenic Escherichia coli infection.
    Puiprom O; Chantaroj S; Matsuda S; Sawanpanyalert P; Honda T; Iida T; Taniguchi T
    Southeast Asian J Trop Med Public Health; 2012 Nov; 43(6):1452-60. PubMed ID: 23413709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli.
    Lasaro MO; Luiz WB; Sbrogio-Almeida ME; Ferreira LC
    Vaccine; 2005 Mar; 23(19):2430-8. PubMed ID: 15752829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of different genes in the CS6 operon for surface expression of Enterotoxigenic Escherichia coli colonization factor CS6.
    Tobias J; Lebens M; Källgård S; Nicklasson M; Svennerholm AM
    Vaccine; 2008 Oct; 26(42):5373-80. PubMed ID: 18708110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the periplasmic chaperone leading to loss of surface expression of the colonization factor CS6 in enterotoxigenic Escherichia coli (ETEC) clinical isolates.
    Nicklasson M; Sjöling A; Lebens M; Tobias J; Janzon A; Brive L; Svennerholm AM
    Microb Pathog; 2008 Mar; 44(3):246-54. PubMed ID: 18037262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration of purified colonization factor antigens (CFA/I, CFA/II) of enterotoxigenic Escherichia coli to volunteers. Response to challenge with virulent enterotoxigenic Escherichia coli.
    Evans DG; Graham DY; Evans DJ
    Gastroenterology; 1984 Oct; 87(4):934-40. PubMed ID: 6381216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Split immune response after oral vaccination of mice with recombinant Escherichia coli Nissle 1917 expressing fimbrial adhesin K88.
    Remer KA; Bartrow M; Roeger B; Moll H; Sonnenborn U; Oelschlaeger TA
    Int J Med Microbiol; 2009 Nov; 299(7):467-78. PubMed ID: 19467927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Co-expression of CFA/I and CS6 of Enterotoxigenic Escherichia coli ( ETEC ) in Shigella flexneri 2a T32 Derivative Strain FWL01].
    Zheng JP; Wang LC; Wang P; Luo G; Li SQ; Duan HQ; Huang CF; Zhang ZS
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Nov; 35(11):1005-10. PubMed ID: 14614538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and phase I clinical evaluation of the safety and immunogenicity of a candidate enterotoxigenic Escherichia coli vaccine strain expressing colonization factor antigen CFA/I.
    Turner AK; Beavis JC; Stephens JC; Greenwood J; Gewert C; Thomas N; Deary A; Casula G; Daley A; Kelly P; Randall R; Darsley MJ
    Infect Immun; 2006 Feb; 74(2):1062-71. PubMed ID: 16428753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen-specific memory B-cell responses to enterotoxigenic Escherichia coli infection in Bangladeshi adults.
    Alam MM; Aktar A; Afrin S; Rahman MA; Aktar S; Uddin T; Rahman MA; Al Mahbuba D; Chowdhury F; Khan AI; Bhuiyan TR; Begum YA; Ryan ET; Calderwood SB; Svennerholm AM; Qadri F
    PLoS Negl Trop Dis; 2014 Apr; 8(4):e2822. PubMed ID: 24762744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral immunization of mice with plant-derived fimbrial adhesin FaeG induces systemic and mucosal K88ad enterotoxigenic Escherichia coli-specific immune responses.
    Liang W; Huang Y; Yang X; Zhou Z; Pan A; Qian B; Huang C; Chen J; Zhang D
    FEMS Immunol Med Microbiol; 2006 Apr; 46(3):393-9. PubMed ID: 16553813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral delivery of Hyperimmune bovine serum antibodies against CS6-expressing enterotoxigenic
    Talaat KR; Porter CK; Bourgeois AL; Lee TK; Duplessis CA; Maciel M; Gutierrez RL; DeNearing B; Adjoodani B; Adkinson R; Testa KJ; Feijoo B; Alcala AN; Brubaker J; Beselman A; Chakraborty S; Sack D; Halpern J; Trop S; Wu H; Jiao J; Sullivan E; Riddle MS; Joseph SS; Poole ST; Prouty MG
    Gut Microbes; 2020 Nov; 12(1):1732852. PubMed ID: 32167011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homologous and cross-reactive immune responses to enterotoxigenic Escherichia coli colonization factors in Bangladeshi children.
    Qadri F; Ahmed F; Ahmed T; Svennerholm AM
    Infect Immun; 2006 Aug; 74(8):4512-8. PubMed ID: 16861637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotypic characterization of Egypt enterotoxigenic Escherichia coli isolates expressing coli surface antigen 6.
    El-Gendy AM; Mansour A; Shaheen HI; Monteville MR; Armstrong AW; El-Sayed N; Young SY; Klena JD
    J Infect Dev Ctries; 2013 Feb; 7(2):90-100. PubMed ID: 23416654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Mucosal Immune Responses to Enterotoxigenic Escherichia coli Vaccine Antigens in a Human Challenge Model: Response Profiles after Primary Infection and Homologous Rechallenge with Strain H10407.
    Chakraborty S; Harro C; DeNearing B; Ram M; Feller A; Cage A; Bauers N; Bourgeois AL; Walker R; Sack DA
    Clin Vaccine Immunol; 2016 Jan; 23(1):55-64. PubMed ID: 26581889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intradermally Administered Enterotoxigenic Escherichia coli Vaccine Candidate MecVax Induces Functional Serum Immunoglobulin G Antibodies against Seven Adhesins (CFA/I and CS1 through CS6) and Both Toxins (STa and LT).
    Garcia CY; Seo H; Sack DA; Zhang W
    Appl Environ Microbiol; 2022 Feb; 88(4):e0213921. PubMed ID: 34936832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein-based vaccine candidate MecVax broadly protects against enterotoxigenic
    Upadhyay I; Parvej SMD; Shen Y; Li S; Lauder KL; Zhang C; Zhang W
    Infect Immun; 2023 Nov; 91(11):e0027223. PubMed ID: 37874163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of PCF8775 antigen and its coli surface subcomponents for colonization, disease, and protective immunogenicity of enterotoxigenic Escherichia coli in rabbits.
    Svennerholm AM; Vidal YL; Holmgren J; McConnell MM; Rowe B
    Infect Immun; 1988 Feb; 56(2):523-8. PubMed ID: 3276628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.